Drug Profile


Alternative Names: STAT3/5 - X-Rx

Latest Information Update: 05 Aug 2016

Price : $50

At a glance

  • Originator X-Rx
  • Class Antineoplastics; Small molecules
  • Mechanism of Action STAT3 transcription factor modulators; STAT5 transcription factor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Research Cancer

Most Recent Events

  • 05 Aug 2016 Early research in Cancer in USA (unspecified route)
  • 05 Aug 2016 STAT3/5 is available for licensing as of 05 Aug 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top